Skip to main content
. Author manuscript; available in PMC: 2018 May 16.
Published in final edited form as: Neurobiol Dis. 2017 May 2;104:85–96. doi: 10.1016/j.nbd.2017.05.002

Table 1.

Summary of mAb improvements in tested outcome measures.

Outcome measure Syn-O1 Syn-O2 Syn-O4 Syn-F1 Syn-F2
Total α-syn levels improved vs. vehicle Neocortex
Hippocampus
Striatum
S. nigra
PK-treated α-syn levels improved vs. vehicle Neocortex
Hippocampus
Striatum
S. nigra
α-Syn levels improved vs. vehicle (ELISA) t-α-syn
h-α-syn
Oligo-α-syn
pS129-α-syn
Aggregated α-syn
Rescue neurodegeneration NeuN
Rescue neuroinflammation GFAP
Iba-1
Iba-1 ramification
Increase colocalization synapsin I and synaptophysin
Reduce colocalization synaptophysin and α-syn
Normalizing behavior Total activity
Rearing
Thigmotaxis